These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Incidence of cancer in 161 families affected by ataxia-telangiectasia. Swift M, Morrell D, Massey RB, Chase CL. N Engl J Med; 1991 Dec 26; 325(26):1831-6. PubMed ID: 1961222 [Abstract] [Full Text] [Related]
4. Breast and other cancers in families with ataxia-telangiectasia. Swift M, Reitnauer PJ, Morrell D, Chase CL. N Engl J Med; 1987 May 21; 316(21):1289-94. PubMed ID: 3574400 [Abstract] [Full Text] [Related]
5. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR. Carcinogenesis; 2006 Mar 21; 27(3):599-605. PubMed ID: 16244359 [Abstract] [Full Text] [Related]
6. Cancer risk of heterozygotes with the NBN founder mutation. Seemanová E, Jarolim P, Seeman P, Varon R, Digweed M, Swift M, Sperling K. J Natl Cancer Inst; 2007 Dec 19; 99(24):1875-80. PubMed ID: 18073374 [Abstract] [Full Text] [Related]
7. Cancer risks in LKB1 germline mutation carriers. Mehenni H, Resta N, Park JG, Miyaki M, Guanti G, Costanza MC. Gut; 2006 Jul 19; 55(7):984-90. PubMed ID: 16407375 [Abstract] [Full Text] [Related]
8. [Ataxia telangiectasia: what impact in clinical oncology?]. Stoppa-Lyonnet D, Aurias A. Bull Cancer; 1992 Jul 19; 79(7):645-50. PubMed ID: 1467590 [Abstract] [Full Text] [Related]
9. Malignant neoplasms in the families of patients with ataxia-telangiectasia. Swift M, Sholman L, Perry M, Chase C. Cancer Res; 1976 Jan 19; 36(1):209-15. PubMed ID: 1248000 [Abstract] [Full Text] [Related]
10. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D. Br J Cancer; 1999 Jun 19; 80(7):1042-5. PubMed ID: 10362113 [Abstract] [Full Text] [Related]
11. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Conway K, Edmiston SN, Cui L, Drouin SS, Pang J, He M, Tse CK, Geradts J, Dressler L, Liu ET, Millikan R, Newman B. Cancer Res; 2002 Apr 01; 62(7):1987-95. PubMed ID: 11929815 [Abstract] [Full Text] [Related]
13. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Lee E, Ma H, McKean-Cowdin R, Van Den Berg D, Bernstein L, Henderson BE, Ursin G. Cancer Epidemiol Biomarkers Prev; 2008 Nov 01; 17(11):3170-8. PubMed ID: 18990759 [Abstract] [Full Text] [Related]
14. Genetic aspects of ataxia-telangiectasia. Swift M. Immunodefic Rev; 1990 Nov 01; 2(1):67-81. PubMed ID: 2196911 [Abstract] [Full Text] [Related]
16. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Roznowski K, Januszkiewicz-Lewandowska D, Mosor M, Pernak M, Litwiniuk M, Nowak J. Breast Cancer Res Treat; 2008 Jul 01; 110(2):343-8. PubMed ID: 17899368 [Abstract] [Full Text] [Related]
18. Timing of familial breast cancer in sisters. Rebora P, Czene K, Reilly M. J Natl Cancer Inst; 2008 May 21; 100(10):721-7. PubMed ID: 18477799 [Abstract] [Full Text] [Related]
20. [Increased risk of malignancies in heterozygotes in families of patients with Nijmegen breakage syndrome]. Seemanová E, Jarolím P, Seeman P, Varon R, Sperling K. Cas Lek Cesk; 2006 May 21; 145(2):138-43. PubMed ID: 16521404 [Abstract] [Full Text] [Related] Page: [Next] [New Search]